Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2014 | 1 |
2020 | 2 |
2021 | 1 |
2024 | 1 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors.
Oncologist. 2024 Apr 4;29(4):e514-e525. doi: 10.1093/oncolo/oyad338.
Oncologist. 2024.
PMID: 38297981
Free PMC article.
Clinical Trial.
The clinical efficacy and safety of single-agent pembrolizumab in patients with recurrent granulosa cell tumors of the ovary: a case series from a phase II basket trial.
How JA, Jazaeri A, Westin SN, Sood AK, Ramondetta LM, Xu M, Abonofal A, Karp DD, Subbiah V, Stephen B, Rodon JA, Yang F, Naing A.
How JA, et al. Among authors: rodon ja.
Invest New Drugs. 2021 Jun;39(3):829-835. doi: 10.1007/s10637-020-01043-9. Epub 2021 Jan 7.
Invest New Drugs. 2021.
PMID: 33415580
Free PMC article.
Clinical Trial.
Item in Clipboard
Phase I, open-label, multicentre study of buparlisib in combination with temozolomide or with concomitant radiation therapy and temozolomide in patients with newly diagnosed glioblastoma.
Wen PY, Rodon JA, Mason W, Beck JT, DeGroot J, Donnet V, Mills D, El-Hashimy M, Rosenthal M.
Wen PY, et al. Among authors: rodon ja.
ESMO Open. 2020 Jul;5(4):e000673. doi: 10.1136/esmoopen-2020-000673.
ESMO Open. 2020.
PMID: 32661186
Free PMC article.
Clinical Trial.
Item in Clipboard
Phase I/IIa, open-label, multicentre study to evaluate the optimal dosing and safety of ODM-203 in patients with advanced or metastatic solid tumours.
Bono P, Massard C, Peltola KJ, Azaro A, Italiano A, Kristeleit RS, Curigliano G, Lassen U, Arkenau HT, Hakulinen P, Garratt C, Ikonen T, Mustonen MVJ, Rodon JA.
Bono P, et al. Among authors: rodon ja.
ESMO Open. 2020 Dec;5(6):e001081. doi: 10.1136/esmoopen-2020-001081.
ESMO Open. 2020.
PMID: 33262202
Free PMC article.
Clinical Trial.
Item in Clipboard
Defining a therapeutic window for the novel TGF-β inhibitor LY2157299 monohydrate based on a pharmacokinetic/pharmacodynamic model.
Gueorguieva I, Cleverly AL, Stauber A, Sada Pillay N, Rodon JA, Miles CP, Yingling JM, Lahn MM.
Gueorguieva I, et al. Among authors: rodon ja.
Br J Clin Pharmacol. 2014 May;77(5):796-807. doi: 10.1111/bcp.12256.
Br J Clin Pharmacol. 2014.
PMID: 24868575
Free PMC article.
Item in Clipboard
Cite
Cite